Related Experiment Video

Updated: Jul 14, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Treatment of advanced head and neck cancer with cetuximab

M Merlano1, O Garrone

  • 1Department of Clinical Oncology, S. Croce General Hospital, Cuneo, Italy. mcmerlano@tisali.it

The International Journal of Biological Markers
|May 24, 2007
PubMed

Insights

Cetuximab, an EGFR inhibitor, shows promise in treating advanced head and neck cancer by potentially enhancing chemotherapy and radiotherapy efficacy. Further clinical research is ongoing.

Area of Science:

  • Oncology
  • Immunotherapy

Background:

  • Cetuximab is a monoclonal antibody targeting the epidermal growth factor receptor (EGFR).
  • EGFR signaling influences tumor growth, angiogenesis, and apoptosis resistance.
  • EGFR inhibition may impact tumor behavior and treatment response.

Purpose of the Study:

  • To review published findings on cetuximab in advanced head and neck cancer.
  • To discuss the potential of cetuximab in combination therapies.
  • To outline future clinical research objectives for cetuximab.

Main Methods:

  • Review of published experimental and clinical data on cetuximab.
  • Analysis of cetuximab's mechanism of action and therapeutic effects.
  • Focus on advanced head and neck cancer treatment.

Main Results:

  • Experimental data suggest cetuximab enhances chemotherapy and radiotherapy.
  • Cetuximab may reverse resistance to certain anticancer drugs.
  • Cetuximab exhibits anticancer activity and supports early clinical findings.

Conclusions:

  • Cetuximab shows potential as a therapeutic agent in advanced head and neck cancer.
  • Combination therapy with cetuximab may improve treatment outcomes.
  • Further clinical research is necessary to define optimal strategies.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...